Courier Therapeutics' Incubator/Accelerator Round

Courier Therapeutics raised a round of funding on August 01, 2016. Investors include JLabs.

Courier is developing a platform technology for precise delivery of cytokines to NK and T cells. The core technology is based on observations about viral stealth proteins that have evolved over millio…

Articles about Courier Therapeutics' Incubator/Accelerator Round: